New EASO framework sets out how Europe can turn major advances in obesity medicines into better, more equitable care New EASO framework sets out how Europe can turn major advances in obesity medicines into better, more equitable care Policy, Position Statements
Global Obesity Forum, 26 October 2026, Madrid, Spain Global Obesity Forum, 26 October 2026, Madrid, Spain Policy, Upcoming Events
Nutritional, Functional and Psychological Considerations for Incretin-Based Therapies in Adults Nutritional, Functional and Psychological Considerations for Incretin-Based Therapies in Adults
Women, Obesity, and Reproductive Health: What Clinicians Need to Know Women, Obesity, and Reproductive Health: What Clinicians Need to Know
Managing obesity related complications with obesity medications Managing obesity related complications with obesity medications
EASO GRADE-Based Framework for the Pharmacological Treatment of Obesity and its Complications EASO GRADE-Based Framework for the Pharmacological Treatment of Obesity and its Complications
Obesity Management Phases: Initiation, Response, and Maintenance Obesity Management Phases: Initiation, Response, and Maintenance
A New Approach to Obesity Diagnosis, Staging, and Management A New Approach to Obesity Diagnosis, Staging, and Management
Neurodevelopmental Disorders and Childhood Obesity Neurodevelopmental Disorders and Childhood Obesity
The Importance of Early Interventions in Childhood Obesity The Importance of Early Interventions in Childhood Obesity
Commercial Determinants of Health: Implications for Health Interventions Commercial Determinants of Health: Implications for Health Interventions
Pharmacotherapy for the Treatment of Obesity in Children and Adolescents Pharmacotherapy for the Treatment of Obesity in Children and Adolescents
Why Eating Less and Moving More is Not the Solution for Obesity Why Eating Less and Moving More is Not the Solution for Obesity
Disseminating Clinical Practice Guidelines for Obesity Disseminating Clinical Practice Guidelines for Obesity